Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/28790
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2022-09-16T12:07:55Z | - |
dc.date.available | 2022-09-16T12:07:55Z | - |
dc.date.issued | 2007-07 | - |
dc.identifier.citation | Akkaya, C. vd. (2007). "Urticaria and angio-oedema due to ziprasidone". Journal of Psychopharmacology, 21(5), 550-552. | en_US |
dc.identifier.issn | 1461-7285 | - |
dc.identifier.issn | 0269-8811 | - |
dc.identifier.uri | https://doi.org/10.1177/0269881106075273 | - |
dc.identifier.uri | https://journals.sagepub.com/doi/10.1177/0269881106075273 | - |
dc.identifier.uri | http://hdl.handle.net/11452/28790 | - |
dc.description.abstract | Antipsychotic medications are commonly associated with adverse cutaneous reactions (ACRs) in approximately 5% of patients. Angio-oedema accompanying unticaria is one of the most serious ACRs. The 36-year-old female patient who was diagnosed with 'Paranoid schizophrenia' 6 years ago, was commenced on ziprasidone 120 mg/day. On day 30 of the treatment, the patient presented urticarial papules and plaques all over the body and angio-oedema in the face. The patient was diagnosed as 'Urticaria+Angio-oedema'. The development of ACRs after the initation of ziprasidone monotherapy, disappearance of Lesions after the discontinuation of this antipsychotic, and positive intradermal skin test all suggests a possible causal relationship between ACRs and ziprasidone. To our knowledge, this is the first reported case of unticaria and angio-oedema due to ziprasidone monotherapy. Ziprasidone is a valid and effective choice amongst antipsychotic medications, but this case calls for caution regarding ACRs at the time of prescribing. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Sage Publications | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Angio-oedema | en_US |
dc.subject | Adverse cutaneous reactions | en_US |
dc.subject | Risperidone | en_US |
dc.subject | Urticaria | en_US |
dc.subject | Ziprasidone | en_US |
dc.subject.mesh | Antipsychotic agents | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Angioneurotic edema | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Piperazines | en_US |
dc.subject.mesh | Schizophrenia, paranoid | en_US |
dc.subject.mesh | Thiazoles | en_US |
dc.subject.mesh | Urticaria | en_US |
dc.title | Urticaria and angio-oedema due to ziprasidone | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000248793200013 | tr_TR |
dc.identifier.scopus | 2-s2.0-34547124577 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Psikiyatri Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Dermatoloji Anabilim Dalı. | tr_TR |
dc.identifier.startpage | 550 | tr_TR |
dc.identifier.endpage | 552 | tr_TR |
dc.identifier.volume | 21 | tr_TR |
dc.identifier.issue | 5 | tr_TR |
dc.relation.journal | Journal of Psychopharmacology | en_US |
dc.contributor.buuauthor | Akkaya, Cengiz | - |
dc.contributor.buuauthor | Sarandöl, Aslı | - |
dc.contributor.buuauthor | Aydoğan, Kenan | - |
dc.contributor.buuauthor | Kirli, Selçuk | - |
dc.identifier.pubmed | 17446198 | tr_TR |
dc.subject.wos | Clinical neurology | en_US |
dc.subject.wos | Neurosciences | en_US |
dc.subject.wos | Pharmacology & pharmacy | en_US |
dc.subject.wos | Psychiatry | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q1 | en_US |
dc.contributor.scopusid | 14061855100 | tr_TR |
dc.contributor.scopusid | 14020405100 | tr_TR |
dc.contributor.scopusid | 9739755800 | tr_TR |
dc.contributor.scopusid | 14019745700 | tr_TR |
dc.subject.scopus | Dexamphetamine; Edema; Adrenergic Receptor Stimulating Agent | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Betamethasone sodium phosphate | en_US |
dc.subject.emtree | Biperiden | en_US |
dc.subject.emtree | Fexofenadine | en_US |
dc.subject.emtree | Haloperidol | en_US |
dc.subject.emtree | Pheniramine maleate | en_US |
dc.subject.emtree | Ziprasidone | en_US |
dc.subject.emtree | Zuclopenthixol | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Priority journal | en_US |
dc.subject.emtree | Angioneurotic edema | en_US |
dc.subject.emtree | Drug withdrawal | en_US |
dc.subject.emtree | Physical examination | en_US |
dc.subject.emtree | Case report | en_US |
dc.subject.emtree | Causal attribution | en_US |
dc.subject.emtree | Consultation | en_US |
dc.subject.emtree | Dermatology | en_US |
dc.subject.emtree | Drug dose increase | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Paranoid schizophrenia | en_US |
dc.subject.emtree | Face edema | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Monotherapy | en_US |
dc.subject.emtree | Papule | en_US |
dc.subject.emtree | Involuntary movement | en_US |
dc.subject.emtree | Rigidity | en_US |
dc.subject.emtree | Side effect | en_US |
dc.subject.emtree | Single drug dose | en_US |
dc.subject.emtree | Skin test | en_US |
dc.subject.emtree | Symptom | en_US |
dc.subject.emtree | Urticaria | en_US |
Appears in Collections: | PubMed Scopus Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.